GenoBank.io is an innovative platform that focuses on patient-led genetic and health testing, emphasizing compliance, security, and privacy. The company utilizes Web3.0 technologies to facilitate the management of genomic data, allowing users to share their laboratory results anonymously with researchers. This approach not only empowers individuals to control their genetic information but also ensures that their data is protected under regulations such as GDPR and CCPA. The platform offers simple consent management, enabling users to participate in various research studies, including those related to COVID-19 vaccine clinical trials and cancer gene research.

In addition to its core services, GenoBank.io collaborates with various research labs and initiatives to enhance the accessibility and effectiveness of genetic research. Notable partners include MDS, which provides tailored solutions for patient care, and Portunus, which focuses on developing biomaterials and prototypes based on advanced biological research. The platform also supports Somos Biobank, aimed at creating a comprehensive Pan American Biobank, and Virodet, which is dedicated to developing low-cost diagnostic kits for COVID-19 detection. Through these collaborations, GenoBank.io aims to contribute significantly to medical science breakthroughs by harnessing the power of health data.

United States

Enabling users to establish #ownership & #control over their Biosamples & derived datasets as Non-fungible Tokens.  We call them #BioNFTs 🧬.

GenoBank.io

Company Details